BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 19785727)

  • 1. Financial incentives to improve adherence to anti-psychotic maintenance medication in non-adherent patients - a cluster randomised controlled trial (FIAT).
    Priebe S; Burton A; Ashby D; Ashcroft R; Burns T; David A; Eldridge S; Firn M; Knapp M; McCabe R
    BMC Psychiatry; 2009 Sep; 9():61. PubMed ID: 19785727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Financial incentives to improve adherence to antipsychotic maintenance medication in non-adherent patients: a cluster randomised controlled trial.
    Priebe S; Bremner SA; Lauber C; Henderson C; Burns T
    Health Technol Assess; 2016 Sep; 20(70):1-122. PubMed ID: 27682868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Money for medication: a randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with psychotic disorders.
    Noordraven EL; Audier CH; Staring AB; Wierdsma AI; Blanken P; van der Hoorn BE; Roijen LH; Mulder CL
    BMC Psychiatry; 2014 Dec; 14():343. PubMed ID: 25438877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial.
    Priebe S; Yeeles K; Bremner S; Lauber C; Eldridge S; Ashby D; David AS; O'Connell N; Forrest A; Burns T
    BMJ; 2013 Oct; 347():f5847. PubMed ID: 24100934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial.
    Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AF; Staring AB; Mulder CL
    Lancet Psychiatry; 2017 Mar; 4(3):199-207. PubMed ID: 28236956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of financial incentives on patients' motivation for treatment: results of "Money for Medication," a randomised controlled trial.
    Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AFT; Mulder CL
    BMC Psychiatry; 2018 May; 18(1):144. PubMed ID: 29793451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled Trial.
    Henderson C; Knapp M; Yeeles K; Bremner S; Eldridge S; David AS; O'Connell N; Burns T; Priebe S
    PLoS One; 2015; 10(10):e0138816. PubMed ID: 26448540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethical acceptability of offering financial incentives for taking antipsychotic depot medication: patients' and clinicians' perspectives after a 12-month randomized controlled trial.
    Noordraven EL; Schermer MHN; Blanken P; Mulder CL; Wierdsma AI
    BMC Psychiatry; 2017 Aug; 17(1):313. PubMed ID: 28851345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Payment for accepting depot medication].
    Mulder CL; Noordraven E; Staring AB
    Ned Tijdschr Geneeskd; 2014; 158(4):A7309. PubMed ID: 24447676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of financial incentives on adherence to antipsychotic depot medication: does it change over time?
    Pavlickova H; Bremner SA; Priebe S
    J Clin Psychiatry; 2015 Aug; 76(8):e1029-34. PubMed ID: 26335089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical and social costs after using financial incentives to improve medication adherence: results of a 1 year randomised controlled trial.
    Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AFT; Mulder CL
    BMC Res Notes; 2018 Sep; 11(1):655. PubMed ID: 30201054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Better quality of life in patients offered financial incentives for taking anti-psychotic medication: Linked to improved adherence or more money?
    Moran K; Priebe S
    Qual Life Res; 2016 Aug; 25(8):1897-902. PubMed ID: 26850023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Financial incentives to improve adherence to medication in five patients with schizophrenia in the Netherlands.
    Staring AB; Mulder CL; Priebe S
    Psychopharmacol Bull; 2010; 43(1):5-10. PubMed ID: 20581796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Offering financial incentives to increase adherence to antipsychotic medication: the clinician experience.
    Highton-Williamson E; Barnicot K; Kareem T; Priebe S
    J Clin Psychopharmacol; 2015 Apr; 35(2):120-7. PubMed ID: 25692797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching antipsychotic medication to reduce sexual dysfunction in people with psychosis: the REMEDY RCT.
    Crawford MJ; Thana L; Evans R; Carne A; O'Connell L; Claringbold A; Saravanamuthu A; Case R; Munjiza J; Jayacodi S; Reilly JG; Hughes E; Hoare Z; Barrett B; Leeson VC; Paton C; Keown P; Pappa S; Green C; Barnes TR
    Health Technol Assess; 2020 Sep; 24(44):1-54. PubMed ID: 32930090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trial to Incentivise Adherence for Diabetes (TRIAD): study protocol for a randomised controlled trial.
    Bilger M; Shah M; Tan NC; Howard KL; Xu HY; Lamoureux EL; Finkelstein EA
    Trials; 2017 Nov; 18(1):551. PubMed ID: 29149912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discontinuing financial incentives for adherence to antipsychotic depot medication: long-term outcomes of a cluster randomised controlled trial.
    Priebe S; Bremner SA; Pavlickova H
    BMJ Open; 2016 Sep; 6(9):e011673. PubMed ID: 27655261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a pilot cluster randomised trial of the use of a Medication Review Tool for people taking antipsychotic medication.
    Moncrieff J; Azam K; Johnson S; Marston L; Morant N; Darton K; Wood N
    BMC Psychiatry; 2016 Jul; 16():205. PubMed ID: 27377549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A contingency management intervention to reduce cannabis use and time to relapse in early psychosis: the CIRCLE RCT.
    Johnson S; Rains LS; Marwaha S; Strang J; Craig T; Weaver T; McCrone P; King M; Fowler D; Pilling S; Marston L; Omar RZ; Craig M; Spencer J; Hinton M
    Health Technol Assess; 2019 Aug; 23(45):1-108. PubMed ID: 31460865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of financial incentives for long-acting injectable antipsychotic adherence in patients with psychotic and bipolar disorders: a systematic review protocol.
    Dennis R; Christian R; Palokas M
    JBI Database System Rev Implement Rep; 2019 Jan; 17(1):43-48. PubMed ID: 30629042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.